This site looks better in landscape mode

AKLRD develops novel solutions for inflammatory diseases with a high unmet need

AKLRD develops novel solutions for inflammatory diseases with a high unmet need

>300M

Worldwide more than 303 million people are affected by osteoarthritis

NEWS

Senescence Research in APPA with INIBIC

Read More

NEWS

Completion of Phase 2a Human Trial

Read More

NEWS

MHRA awards Innovation Passport for APPA in Osteoarthritis

Read More

NEWS

 

Senescence Research in APPA with INIBIC

Read More

 

Completion of Phase 2a Human Trial

Read More

 

MHRA awards Innovation Passport for APPA in Osteoarthritis

Read More